Kayne Anderson Rudnick Investment Management LLC Laboratory Corp Of America Holdings Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$197.69 - $227.29 $593 - $681	3 Added 33.33%	12 $2,000
Q2 2023 Aug 11, 2023	BUY	$211.93 - $241.33 $211 - $241	1 Added 12.5%	9 $2,000
Q3 2022 Nov 16, 2022	BUY	$204.81 - $262.19 $1,638 - $2,097	8 New	8 $2,000
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $1,638 - $2,097	-8 Closed	0 $2,000
Q2 2022 Aug 12, 2022	SELL	$213.86 - $277.87 $21,386 - $27,787	-100 Reduced 92.59%	8 $2,000
Q1 2021 May 17, 2021	BUY	$204.88 - $255.03 $20,488 - $25,503	100 Added 1250.0%	108 $28,000
Q4 2019 Feb 13, 2020	BUY	$163.48 - $173.61 $1,307 - $1,388	8 New	8 $1,000

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account